Millions worldwide turn to traditional Chinese medicine for things like acupuncture, herbal remedies, and therapeutic massages. Now, a recent study reveals that a specific treatment from traditional Chinese medicine can significantly reduce hospitalization rates and cardiovascular death in heart failure patients.
Qiliqiangxin is an extract derived from 11 types of herbs. In earlier research, it was found that qiliqiangxin reduced levels of N-terminal pro–B-type natriuretic peptide (NT-proBNP) and improved heart failure symptoms when added to standard heart failure treatments. Preclinical studies have also shown its potential to attenuate myocardial fibrosis and cardiac remodeling.
The QUEST trial aimed to assess the clinical effectiveness and safety of qiliqiangxin on major heart failure outcomes in heart failure in reduced ejection fraction (HFrEF) patients. It was conducted at 133 hospitals in mainland China and Hong Kong SAR of China.
